Current status,hot spots and trends in pharmaceutical regulatory science research:a bibliometric analysis based on Web of ScienceLIU Qiang, MAO Zhen-bin, HUANG Zhe1185-1193
Textual analysis of provincial(municipal)biomedical industry quality development policies from the perspective of policy toolsSHENG Tian-yi, JIANG Rong, SHAO Rong1194-1200
International comparison of the development methods and results of the SF-6D value setsHU Hong-fei, LI Feng, ZHOU Ting1201-1209
Status and analysis of drug registration application in the Guangdong-Hong Kong-Macao Greater Bay Area in 2018-2022LI Lan-lan, TAN Meng-si, CHENG Bin, HUANG Xiao-long1210-1218
The focus of chemical manufacturing and control evaluation of 60Co gamma-sterilization on chemical drugsCHENG Si-qi, ZHANG Yun, WANG Ya-min1219-1223
Quality control study of recombinant anti-amyloid-β monoclonal antibodyWU Gang, YU Chuan-fei, LI Meng, CUI Yong-fei, GUO Lu-yun, MEI Yu-ting, YANG Ya-lan, XU Gang-ling, WANG Lan1224-1232
Research progress in radiolabelling synthesis of[18F]FDOPAPENG Can, DONG Guo-sheng, LI Xi-chen, LI Zheng, HAN Yu-fei, ZHANG Tao1233-1242
Advances in pharmacokinetic and pharmacodynamic studies of novel dual orexin receptor antagonists on the marketCHEN Xiang, WANG Hui-ze, YU Guo1243-1249
Advances in the co-culture models for evaluating gastrointestinal toxicity in vitroLI Ying-qi, FENG Tian-yi, WEI Li-ping, CHANG Yan1250-1255
The clinical efficacy evaluation of remimazolam-induced sleeping balance in chronic insomniaHU Qi-yun, XU Sen, LIU Yu-si, LI Wan-wen, HAN Liang, WANG Wen-yuan1256-1261